• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.52% Nasdaq Down0.25%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    1.37 Down 0.03(1.79%) 4:00PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):3.0
    Mean Recommendation (last week):2.5
    Change:0.5

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:2.04
    Median Target:2.00
    High Target:3.00
    Low Target:1.00
    No. of Brokers:6

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jul 24, 2015Cantor FitzgeraldDowngradeBuyHold
    Jul 24, 2015ROTH CapitalDowngradeBuySell
    Dec 15, 2014ROTH CapitalUpgradeNeutralBuy
    Oct 7, 2014RBC Capital MktsDowngradeOutperformSector Perform
    Oct 7, 2014ROTH CapitalDowngradeBuyNeutral
    Jun 12, 2014UBSInitiated Buy
    May 29, 2012RBC Capital MktsUpgradeSector PerformOutperform
    Apr 13, 2012Cantor FitzgeraldInitiated Buy
    Mar 6, 2012Canaccord GenuityInitiated Buy
    Oct 11, 2011RBC Capital MktsDowngradeOutperformSector Perform

    More Upgrades & Downgrades for SNSS

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy1111
    Buy3333
    Hold3333
    Underperform1111
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.